JOURNAL OF MEDICAL GENETICS, published by the BMJ PUBLISHING GROUP, stands as a premier platform in the field of genetics, focusing on both fundamental genetic research and its clinical applications. With a distinctive legacy dating back to 1965 and a significant role in advancing the understanding of genetic disorders, this journal has established itself in the top tiers with a commendable Q1 category ranking in both Genetics and Clinical Genetics as of 2023. The journal's impact is underscored by its Scopus rankings, placing it among the leading journals in the fields of medicine and genetics. Researchers and practitioners are drawn to its rigorous peer-review process and its commitment to disseminating high-quality research findings, critical reviews, and innovative clinical practices. While it is not an open-access journal, the insights provided are invaluable for anyone looking to deepen their knowledge or contribute to the burgeoning field of medical genetics.

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, published by Elsevier, is a renowned journal that explores critical advancements in the field of genetic toxicology and environmental mutagenesis. With an ISSN of 1383-5718 and an E-ISSN of 1879-3592, it ranks in Q3 for Genetics and Q2 for Health, Toxicology, and Mutagenesis as of 2023. This journal not only emphasizes the importance of environmental factors in genetic material alterations but also disseminates significant research findings that aid in understanding the implications for public health and safety. Operating from Amsterdam, Netherlands, it serves as a pivotal platform for researchers, professionals, and students, fostering an informed community keen on evolving the parameters of genetic research. Although it currently does not offer open access, the journal's commitment to high-quality peer-reviewed content ensures substantial contributions to the academic literature, enhancing our comprehension of mutagenic processes and their environmental triggers.

Genome Research, published by Cold Spring Harbor Laboratory Press, stands as a premier journal in the field of genetics, featuring rigorous peer-reviewed research that explores the complexities of genome organization and function. With an impressive Q1 ranking in both Genetics and Clinical Genetics according to the 2023 category quartiles, this journal effectively bridges the gap between fundamental genetic science and its clinical applications. Its significance is further highlighted by its Scopus rankings, where it ranks #6 out of 99 in Clinical Genetics and #27 out of 347 in Biochemistry, Genetics, and Molecular Biology, showcasing its broad influence and access to cutting-edge discoveries. Researchers and professionals can look forward to a diverse array of articles that cover genomic technologies, bioinformatics, and translational genomics. Although not currently open access, the wealth of information available in each issue makes it an invaluable resource for anyone engaged in genetic research and applications.

Gene Reports is a prominent academic journal published by Elsevier that focuses on the rapidly evolving field of genetics. Launched in 2015, this journal serves as a pivotal platform for the dissemination of cutting-edge research, bridging the gap between basic and applied genetics studies. Although it currently holds a Q4 ranking in the Genetics category and stands at the 248th position out of 347 in Scopus rankings, its potential for growth is significant given the increasing interest in genetic research across various disciplines. With an E-ISSN of 2452-0144, Gene Reports aims to provide open access to original research articles, reviews, and short communications that advance the collective understanding of genetic mechanisms and their applications. As a publication that continues to shape the future of genetics, it is an essential resource for researchers, professionals, and students seeking to stay informed about the latest developments in this crucial field.

Molecular Syndromology is a premier journal focused on the intricate connections between molecular genetics and syndromology, fostering discussions that advance our understanding of genetic disorders and their clinical implications. Published by KARGER, a distinguished name in medical and scientific publishing, this journal serves as a valuable platform for researchers, clinicians, and students in the field of genetics. With its ISSN 1661-8769 and E-ISSN 1661-8777, the journal has gained recognition in its category, currently positioned in the Q4 quartile for both genetic and clinical genetics disciplines according to the latest metrics. Despite being indexed lower in Scopus rankings, it addresses crucial gaps in research and offers open access options that enhance visibility and dissemination of knowledge. As it continues to converge from 2010 to 2024, Molecular Syndromology aims to bridge the gap between molecular research and its clinical applications, making a significant impact in the evolving landscape of genetic medicine.

CURRENT GENETICS is a prestigious journal published by SPRINGER, dedicated to advancing the field of genetics through the dissemination of high-quality research. With a notable impact factor and ranking in the Q2 category for both Genetics and Medicine (miscellaneous) as of 2023, it firmly establishes itself as a significant resource for the academic community. The journal’s comprehensive scope explores the latest findings in genetic research, along with accompanying interdisciplinary studies, providing a platform for researchers to share innovative ideas and methodologies. ISSN: 0172-8083, E-ISSN: 1432-0983, stands testament to its commitment to scholarly excellence. While Open Access options are not currently available, CURRENT GENETICS remains accessible to a broad audience, promoting a rich exchange of knowledge that supports the vast and evolving discipline of genetics. Since its inception in 1979 and through its converged years till 2024, this journal has played a crucial role in confronting scientific challenges and promoting advancements in genomic medicine and molecular biology. As such, it is an essential read for researchers, professionals, and students keen to remain at the forefront of genetic research.

Journal of Pediatric Genetics, published by GEORG THIEME VERLAG KG, is an essential resource in the field of pediatric medicine and genetics. With a focus on the genetic determinants of health and disease in children, this journal aims to advance the knowledge and application of genetic research in pediatric care. Although it has faced challenges in its indexing in recent years, it provides an important platform for practitioners and researchers dedicated to understanding the complexities of pediatric genetics. As evidenced by its position in Scopus ranks—ranked #209 in Pediatrics and #87 in Clinical Genetics—the journal serves a niche yet critical audience seeking to explore the interplay between genetic factors and childhood health outcomes. The Journal of Pediatric Genetics invites scholars and professionals to delve into its rich content, contributing to the ongoing discourse in this vital field, while the absence of open access highlights the journal’s curation of high-quality, peer-reviewed articles that are valued across academia and clinical practices.

CARCINOGENESIS, published by Oxford University Press, is a premier journal dedicated to the nuanced field of cancer research. With an ISSN of 0143-3334 and an E-ISSN of 1460-2180, this esteemed journal plays a crucial role in disseminating high-quality research findings since its inception in 1980, making it a cornerstone in the exploration of carcinogenic processes. As of 2023, it stands out with a commendable Q2 ranking in Cancer Research and a Q1 ranking in Medicine (miscellaneous), reflecting its significant impact in advancing knowledge in these vital areas. Supported by a strong Scopus ranking, specifically holding the 61st position out of 230 in Biochemistry, Genetics, and Molecular Biology within Cancer Research, CARCINOGENESIS provides researchers, healthcare professionals, and students access to peer-reviewed articles that cover a broad spectrum of topics related to cancer etiology, prevention, and treatment. Although it is not an open-access journal, its commitment to excellence ensures that every published article contributes meaningfully to the global fight against cancer, making it an essential resource for those engaged in cutting-edge cancer research.

ARCHIVES OF TOXICOLOGY is a prestigious journal published by Springer Heidelberg, dedicated to advancing research in the field of toxicology and related disciplines. With a distinguished history dating back to 1930, this journal has continuously provided vital insights and groundbreaking studies, making it a cornerstone in the areas of health, toxicology, and medicine. Recognized for its high impact, it occupies a top-ranking position in Scopus, with remarkable quartile placements in 2023, categorizing it as Q1 in Health, Toxicology and Mutagenesis, and Q1 in Medicine (Miscellaneous). The journal highlights critical research and innovative methodologies, appealing to a diverse audience of researchers, professionals, and students committed to understanding the complexities of toxic substances and their implications for public health and environmental safety. The journal does not currently offer open access, allowing for a more traditional but rigorous peer-review process that ensures the quality and integrity of every published article. Join the global discourse in toxicological science with ARCHIVES OF TOXICOLOGY, where every contribution furthers the understanding of safety and toxicity in our world.

MUTAGENESIS, published by Oxford University Press, is a leading journal in the fields of genetics, toxicology, and health, dedicated to advancing our understanding of mutagenic processes and their implications for human health. With an ISSN of 0267-8357 and an E-ISSN of 1464-3804, this journal has been at the forefront of mutagenesis research since its inception in 1986 and will continue to publish cutting-edge studies until 2024. Holding an impressive position in the academic community, MUTAGENESIS is ranked Q2 in Genetics, Q2 in Clinical Genetics, Q2 in Health, Toxicology, and Mutagenesis, and Q1 in Toxicology, reflecting its commitment to high-quality scholarly work. The journal enjoys a robust global readership, with significant rankings in various Scopus categories, including top positions in Environmental Science and Clinical Genetics, ensuring that it remains a vital resource for researchers, professionals, and students alike. While access to its articles is not completely open, MUTAGENESIS provides valuable insights that fuel innovative research and drive forward the understanding of genetic risks and toxicological assessments.